Table III.
Univariate and multivariate Cox analyses of hepatocellular carcinoma clinical characteristics and SOCS2 expression.
| Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|
| Variable | HR (95% CI) | P-value | HR (95% CI) | P-value |
| Age | 1.005 (0.986–1.024) | 0.593 | – | – |
| Gender | 1.033 (0.565–1.888) | 0.916 | – | – |
| Stage | ||||
| I | 2.338 (1.245–4.392) | 0.008 | 2.295 (1.093–4.821) | 0.028 |
| II | 0.657 (0.347–1.245) | 0.198 | – | – |
| III/IV | 0.517 (0.270–0.989) | 0.046 | 1.128 (0.512–2.485) | 0.765 |
| SOCS2 | 0.968 (0.942–0.994) | 0.018 | 0.968 (0.941–0.996) | 0.024 |
SOCS2, suppressor of cytokine signaling 2; HR, hazard ratio; CI, confidence interval; -, not applicable.